Inventor · disambiguated record
Eddy W. Yue
Also filed as: YUE EDDY · YUE EDDY W · YUE EDDY WAI TSUN
71 granted patents·30 pending applications·1,274 citations·filing 2000–2025
99Inventor score
Top patents by PatentIndex Score
101 records- 0198US10376513B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2018·Granted Aug 13, 2019·12 cites·21 claims
- 0298US9199982B2Heterocyclylamines as PI3K inhibitorsLI YUN-LONG·Filed 2012·Granted Dec 1, 2015·52 cites·15 claims
- 0398US8088803B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseCOMBS ANDREW P·Filed 2009·Granted Jan 3, 2012·64 cites·30 claims
- 0497US10138248B2Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitorsINCYTE CORP·Filed 2017·Granted Nov 27, 2018·36 cites·24 claims
- 0597US10092570B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2017·Granted Oct 9, 2018·17 cites·20 claims
- 0697US10065963B2Heterocyclic compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2016·Granted Sep 4, 2018·16 cites·14 claims
- 0797US9918990B2Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitorsINCYTE CORP·Filed 2016·Granted Mar 20, 2018·23 cites·58 claims
- 0897US9737516B2Bicyclic heterocycles as bet protein inhibitorsINCYTE CORP·Filed 2016·Granted Aug 22, 2017·25 cites·52 claims
- 0997US9730939B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2015·Granted Aug 15, 2017·23 cites·7 claims
- 1097US9707233B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2015·Granted Jul 18, 2017·23 cites·21 claims
- 1197US9399640B2Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitorsINCYTE CORP·Filed 2014·Granted Jul 26, 2016·37 cites·60 claims
- 1297US9096600B2N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitorsLI YUN-LONG·Filed 2011·Granted Aug 4, 2015·47 cites·28 claims
- 1397US8993605B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2014·Granted Mar 31, 2015·34 cites·15 claims
- 1497US8759359B2Substituted heteroaryl fused derivatives as PI3K inhibitorsCOMBS ANDREW P·Filed 2010·Granted Jun 24, 2014·64 cites·25 claims
- 1596US10472368B2Heterocyclic compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2018·Granted Nov 12, 2019·12 cites·28 claims
- 1696US9850257B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2016·Granted Dec 26, 2017·22 cites·39 claims
- 1796US9815839B2N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitorsINCYTE CORP·Filed 2016·Granted Nov 14, 2017·20 cites·16 claims
- 1896US9527848B2N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitorsINCYTE CORP·Filed 2015·Granted Dec 27, 2016·25 cites·12 claims
- 1996US9320732B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2015·Granted Apr 26, 2016·14 cites·9 claims
- 2096US9315501B2Bicyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2014·Granted Apr 19, 2016·33 cites·41 claims
- 2196US9290514B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2014·Granted Mar 22, 2016·33 cites·44 claims
- 2296US9126948B2Pyrimidine-4,6-diamine derivatives as PI3K inhibitorsCOMBS ANDREW P·Filed 2012·Granted Sep 8, 2015·27 cites·31 claims
- 2396US8822511B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2013·Granted Sep 2, 2014·24 cites·36 claims
- 2496US8680108B2Substituted fused aryl and heteroaryl derivatives as PI3K inhibitorsLI YUN-LONG·Filed 2010·Granted Mar 25, 2014·62 cites·28 claims
- 2596US8034953B2Modulators of indoleamine 2,3-dioxygenase and methods of using the sameINCYTE CORP·Filed 2006·Granted Oct 11, 2011·45 cites·28 claims
- 2695US11780840B2Tricyclic urea compounds as JAK2 V617F inhibitorsINCYTE CORP·Filed 2021·Granted Oct 10, 2023·4 cites·12 claims
- 2795US11433071B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2020·Granted Sep 6, 2022·3 cites·20 claims
- 2895US11225486B2Tertiary alcohols as PI3K-γ inhibitorsINCYTE CORP·Filed 2020·Granted Jan 18, 2022·4 cites·51 claims
- 2995US9789094B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2016·Granted Oct 17, 2017·11 cites·23 claims
- 3095US8846726B2Modulators of indoleamine 2,3-dioxygenase and methods of using the sameINCYTE CORP·Filed 2013·Granted Sep 30, 2014·23 cites·38 claims
- 3195US8796319B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseCOMBS ANDREW P·Filed 2011·Granted Aug 5, 2014·21 cites·68 claims
- 3295US6291504B1Acylsemicarbazides and their usesDU PONT PHARM CO·Filed 2000·Granted Sep 18, 2001·125 cites·59 claims
- 3394US11819505B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2022·Granted Nov 21, 2023·1 cites·6 claims
- 3494US10034864B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2017·Granted Jul 31, 2018·8 cites·20 claims
- 3594US9108984B2Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitorsCOMBS ANDREW P·Filed 2012·Granted Aug 18, 2015·32 cites·32 claims
- 3693US11926630B2Tertiary alcohols as PI3K-γ inhibitorsINCYTE CORP·Filed 2021·Granted Mar 12, 2024·2 cites·2 claims
- 3793US10975088B2Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitorsINCYTE CORP·Filed 2019·Granted Apr 13, 2021·6 cites·13 claims
- 3893US10479795B2Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitorsINCYTE CORP·Filed 2018·Granted Nov 19, 2019·13 cites·45 claims
- 3993US8372870B2Modulators of indoleamine 2,3-dioxygenase and methods of using the same for treating cancerINCYTE CORP·Filed 2011·Granted Feb 12, 2013·17 cites·33 claims
- 4092US10369137B21,2,5-Oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2018·Granted Aug 6, 2019·5 cites·4 claims
- 4192US9193721B2Fused derivatives as PI3Kδ inhibitorsCOMBS ANDREW P·Filed 2011·Granted Nov 24, 2015·26 cites·39 claims
- 4292US8377976B2N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2011·Granted Feb 19, 2013·24 cites·9 claims
- 4391US10653677B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2019·Granted May 19, 2020·4 cites·20 claims
- 4491US6407103B2Indeno [1,2-c] pyrazol-4-ones and their usesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Jun 18, 2002·43 cites·57 claims
- 4591US2025325550A1Heterocyclylamines as pi3k inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 4690US11046658B2Aminopyrazine derivatives as PI3K-γ inhibitorsINCYTE CORP·Filed 2019·Granted Jun 29, 2021·4 cites·23 claims
- 4789US12201636B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2023·Granted Jan 21, 2025·0 cites·8 claims
- 4889US12173006B2Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitorINCYTE CORP·Filed 2021·Granted Dec 24, 2024·1 cites·12 claims
- 4989US10208002B2Modulators of indoleamine 2,3-dioxygenase and methods of using the sameINCYTE CORP·Filed 2017·Granted Feb 19, 2019·5 cites·20 claims
- 5089US9932341B2Use of pyrazolopyrimidine derivatives for the treatment of PI3K-delta related disordersINCYTE CORP·Filed 2014·Granted Apr 3, 2018·9 cites·50 claims
Showing the top 50 of 101 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →